2
H index
0
i10 index
26
Citations
Márta Péntek : Citation Profile
Budapesti Corvinus Egyetem | RESEARCH PRODUCTION: 20 Articles 2 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
13 years (2003 - 2016). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Márta Péntek. | Is cited by:
| Cites to:
|
Main data
Where Márta Péntek has published?
| Journals with more than one article published | # docs |
|---|---|
| The European Journal of Health Economics | 17 |
| Health Policy | 2 |
Recent works citing Márta Péntek (2018 and 2017)
| Year | Title of citing document |
|---|---|
| 2019 | Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?. (2019). Trapero-Bertran, M ; Aranda-Reneo, I ; Ramos-Goi, J M ; Lopez-Bastida, J ; Martin, Rodriguez B ; Kanavos, P. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:152-158. Full description at Econpapers || Download paper |
| 2019 | HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey. (2019). Martinez, Araceli Caro ; de Labry, Antonio Olry ; Balbino, Jaime Espin ; Garcia-Mochon, Leticia ; Velasco, Roman Perez ; Ruiz, Eva Martin. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:182-190. Full description at Econpapers || Download paper |
| 2017 | Acceptable health and priority weighting: Discussing a reference-level approach using sufficientarian reasoning. (2017). van Exel, Job ; Brouwer, Werner ; Vromen, J J ; Wouters, S. In: Social Science & Medicine. RePEc:eee:socmed:v:181:y:2017:i:c:p:158-167. Full description at Econpapers || Download paper |
| 2019 | From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue. (2019). Zanda, Stefania ; Lettieri, Mattia ; Caputo, Francesco ; Barile, Sergio ; Saviano, Marialuisa. In: Sustainability. RePEc:gam:jsusta:v:11:y:2019:i:5:p:1289-:d:210054. Full description at Econpapers || Download paper |
| 2018 | Health Expenditure, GDP Growth and the Financial Crisis: A Panel Data Analysis for OECD European Countries. (2018). Almeida, Alvaro S ; Cima, Joana . In: FEP Working Papers. RePEc:por:fepwps:602. Full description at Econpapers || Download paper |
| 2017 | Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD). (2017). Brodszky, Valentin ; Baji, Petra ; Rencz, Fanni ; Hever, Noemi V ; Pentek, Marta ; Gulacsi, Laszlo ; Papp, Szilvia ; Bitter, Istvan ; Pulay, Attila J. In: Applied Research in Quality of Life. RePEc:spr:ariqol:v:12:y:2017:i:2:d:10.1007_s11482-016-9467-6. Full description at Econpapers || Download paper |
| 2017 | Economic impact of patients admitted to stroke units in Spain. (2017). oliva, juan ; Yebenes, Maria ; Torres, Covadonga ; Becerra, Virginia ; Gonzalez-Rojas, Nuria ; Mar, Javier ; Oliva-Moreno, Juan ; Masjuan, Jaime ; Quintana, Manuel ; Alvarez-Sabin, Jose . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0799-9. Full description at Econpapers || Download paper |
| 2017 | Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis. (2017). Simoens, Steven ; Shane, Lesley G ; Isakov, Leah ; Popovian, Robert ; Jacobs, Ira. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0529-x. Full description at Econpapers || Download paper |
Works by Márta Péntek:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2015 | The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? In: Society and Economy. [Full Text][Citation analysis] | article | 1 |
| 2015 | The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?.(2015) In: Corvinus Economics Working Papers (CEWP). [Full Text][Citation analysis] This paper has another version. Agregated cites: 1 | paper | |
| 2015 | Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists In: Corvinus Economics Working Papers (CEWP). [Full Text][Citation analysis] | paper | 0 |
| 2012 | Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study In: Health Policy. [Full Text][Citation analysis] | article | 1 |
| 2003 | Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary In: Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2010 | The disease burden of colorectal cancer in Hungary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2012 | Health economics and health technology assessment in Central and Eastern Europe: a dose of reality In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2014 | Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2014 | Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2014 | Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2014 | Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2014 | Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2014 | HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2016 | Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2016 | Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2016 | Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2016 | Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2016 | Social/economic costs and health-related quality of life in patients with scleroderma in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 3 |
| 2016 | Social/economic costs and health-related quality of life in patients with histiocytosis in Europe In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2020. Contact: CitEc Team